Granted this CC may have been of the sell the news type and I can understand shoting IMCL after approval and DNA after the pop the other day but DNDN is only a teeny bopper with potential major news and you might get a pull back of a buck if that from here but if you think its going to single digits you will likely be waiting and hoping till FDA gives thumbs down which as we know you believe drug doesnt work based on results of 2 yrs ago ?? You never gave me the links to the data you quoted so not sure of how old of info you base your opinion. That said new data has arrived Jan 12th and some investors liked it enough to buy $150 million of DNDN stock in secondary...you wil be fighting an uphill battle....according to CC the partnership is on schedule....if you think you know better than the company and a potential partner such as perhaps DNA and those who poured $150 mil into DNDN as far as the drug working or not then more power to ya and it is possible you could be right as it either does or it doesnt show benefit to patients so you a 50 / 50 chance but to go against the trend at this juncture is gonna cost ya as it already has for not covering on last pullback to $12. As I told you before it was obvious to reverse postitons at that time and you could have reversed yet again this morning and been breathing alot easier. Dont get married to a position...go with flow....you will be glad you did.